ストックスクリーナーアプリを入手
3.92
0.13%
0.005
前日終値:
$3.915
開ける：
$3.92
24時間の取引高:
1.08M
Relative Volume:
1.67
時価総額：
$1.33B
収益：
$563.46M
当期純損益:
$27.92M
株価収益率:
40.66
EPS:
0.0964
ネットキャッシュフロー:
$-146.33M
1週間 パフォーマンス:
-7.11%
1か月 パフォーマンス:
+20.62%
6か月 パフォーマンス:
-17.12%
1年 パフォーマンス:
-56.49%
1日の値動き範囲:
$3.835
$4.01
1週間の範囲:
$3.75
$4.45
52週間の値動き範囲:
$2.94
$9.94
Alvotech Stock (ALVO) Company Profile
Compare ALVO vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
3.92 | 1.33B | 563.46M | 27.92M | -146.33M | 0.0964 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Underweight |
| 2025-11-04 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-10-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-02-14 | 開始されました | UBS | Buy |
| 2024-01-29 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-10-20 | アップグレード | Citigroup | Sell → Neutral |
| 2023-09-21 | 開始されました | Barclays | Equal Weight |
| 2022-09-07 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-09-06 | ダウングレード | Citigroup | Buy → Sell |
| 2022-07-26 | 開始されました | Citigroup | Buy |
すべてを表示
Alvotech (ALVO) 最新ニュース
Alvotech (NASDAQ: ALVO) secures $165M through share sale and private placement - Stock Titan
Alvotech completes offering and raises ~$165 million - The Pharma Letter
symbol__ Stock Quote Price and Forecast - CNN
Alvotech initiates $125M fundraising via public and private offering for biosimilar growth - MSN
Alvotech closes $98M public offering at $3.75 per share - Investing.com UK
Alvotech closes $98M public offering at $3.75 per share By Investing.com - Investing.com South Africa
Alvotech Raises $165 Million Through A Two-Step Share Sale - Finimize
Alvotech Launches New $125 Million Public Offering, Private Placement - marketscreener.com
Alvotech launches public offering targeting $125 million By Investing.com - Investing.com South Africa
Alvotech Closes Public Offering and Announces Concurrent Private Placement to Raise Approximately $165 Million - Quiver Quantitative
Alvotech launches public offering targeting $125 million - Investing.com UK
Alvotech seeks $125M in shares for biosimilar development - Stock Titan
Nordic Shares Decrease; Alvotech SDR Takes Biggest Hit - Moomoo
Alvotech (NASDAQ: ALVO) raises up to $165M in offering and PIPE - Stock Titan
Alvotech (NASDAQ: ALVO) priced 22.7M-share offering at $3.75; concurrent private placement - Stock Titan
ALVO SEC FilingsAlvotech 10-K, 10-Q, 8-K Forms - Stock Titan
ALVO Secures Funding with Share Offerings - GuruFocus
Alvotech Secures Fresh Cash As FDA Milestones Mount - Citeline News & Insights
Alvotech stock tumbles after $152 million equity raise By Investing.com - Investing.com Nigeria
Alvotech stock tumbles after $152 million equity raise - Investing.com
Alvotech Lines Up $152 Million For Biosimilar Development - Finimize
Dave and Buster's Reports Downbeat Q1 Earnings, Joins Alvotech And Other Big Stocks Moving Lower In Tuesd - Benzinga
Alvotech raises $152 million via two issues - Biostock
Alvotech Prices Share Offering, Private Placement - 富途牛牛
Biotech Alvotech aims to raise up to $165M for biosimilar pipeline - Stock Titan
Alvotech prices $152M share offering and private placement to fund biosimilar development - Pluang
Alvotech Prices Public Offering of 22.7 Million Ordinary Shares at $3.75 per Share - Quiver Quantitative
Alvotech Prices Offering Of 22.67 Million Ordinary Shares At $3.75 Per Share - TradingView
Jefferies (JEF) Involved in Alvotech's Share Issuance Suspension - GuruFocus
Alvotech's $125M Gamble: Fueling a Biosimilar Pipeline Amidst Headwinds - BriefGlance
Alvotech (ALVO) launches shelf offering; concurrent EEA private placement indicated - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market SessionAlvotech (NASDAQ:ALVO), Anixa Biosciences - Benzinga
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares - The Manila Times
Alvotech (ALVO) terminates Jefferies ATM share prospectus - Stock Titan
Alvotech Stock (LU2557688560): Nordic-listed biosimilar player draws focus after latest trading move - AD HOC NEWS
Alvotech seeks FDA nod for Simponi, Eylea biosimilars again - Drug Store News
Alvotech announced that it expects to receive $66.849998 million in funding - marketscreener.com
Why Alvotech (ALVO) Is Up 17.8% After FDA Advances Its Entyvio Biosimilar AVT16 Application - simplywall.st
Alvotech hits critical inflection as biosimilar pipeline nears FDA decisions - MSN
Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock? - The Motley Fool
Alvotech shares jump after FDA accepts Entyvio biosimilar application for review (ALVO) - MSN
Alvotech gains on FDA acceptance of Entyvio biosimilar BLA - MSN
Alvotech allocates shares to a board director as part of his pay package, filed with Luxembourg regulator. - Pluang
Transactions of Managers and Closely Associated Persons - Stock Titan
Alvotech Hits Critical Inflection as Biosimilar Pipeline Nears FDA Decisions - MarketBeat
Transcript : Alvotech Presents at UBS Virtual Generics and Biosimilars Day, Jun-10-2026 10 - marketscreener.com
Alvotech seeks US nod for biosimilars to J&J’s Simponi and Regeneron’s Eylea again - MSN
ALVO: Poised for rapid biosimilar expansion, targeting key launches and market leadership by 2027 - TradingView
Alvotech (ALVO) Returns To Quarterly Profitability Challenging Concern Over Persistent Losses - simplywall.st
Alvotech resubmits BLA for proposed Eylea biosimilar - Eyes On Eyecare
Alvotech (ALVO) 財務データ
収益
当期純利益
現金流量
EPS
11.23%
0.45%
大文字化:
|
ボリューム (24 時間):